| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/26/2003 | EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use |
| 02/26/2003 | EP0708763B1 Process for making hiv protease inhibitors |
| 02/26/2003 | CN1398857A Synthesis of benzoxazolinone |
| 02/25/2003 | US6525211 Herbicidal sulphonylamino(thio)carbonyl compounds |
| 02/25/2003 | US6525193 Aminoaryl oxazolidinone N-oxides |
| 02/25/2003 | US6525096 4-amino-3-(2-methylpropyl)butanolc acid; central nervous system disorders such as epilepsy, Huntington's chorea, cerebral ischernia, Parkinson's disease, tardive dyskinesia, and spasticity |
| 02/25/2003 | US6525086 Compounds, their preparation and use |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/21/2003 | WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/19/2003 | EP1283838A1 Piperazine and piperidine compounds |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP0750618B1 Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 02/19/2003 | CN1101812C Acorus calamus extracts in Acorus gramineus and their use |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011819A1 Butyric acid derivatives |
| 02/13/2003 | WO2003011799A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| 02/13/2003 | WO2002036580A9 Benzoxazole lpaat- beta inhibitors and uses thereof |
| 02/13/2003 | WO2001077107A8 Oxazole derivatives and their uses as tyrosine kinase inhibitors |
| 02/13/2003 | US20030032671 Propionic acid derivatives |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032635 Heterocyclic esters and amides |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2456166A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 02/13/2003 | CA2455749A1 Butyric acid derivatives |
| 02/12/2003 | EP1283205A1 Naphthol derivatives |
| 02/12/2003 | EP1283204A1 Methods for crystallization of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride |
| 02/12/2003 | EP1282619A1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
| 02/12/2003 | EP1282601A1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salt thereof |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | EP0861239B1 Biphenyl ether oxazolines and their use as pest-control agents |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/11/2003 | US6518435 Production method, a method of producing a compound represented by the formula (III) production method of oxyimino- alkanoic acid derivatives having an anti-diabetic activity. |
| 02/11/2003 | US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines. |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518048 Hydrogenation a isophthalic acid derivative |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003010142A2 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5 -dioxo-oxazolidine intermediate compounds |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | US20030028029 Process for production of piperidine derivatives |
| 02/06/2003 | US20030027859 3-aryl-2-hydroxypropionic acid derivative I |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/05/2003 | EP1281704A1 Process for the the preparation of substituted oxazoles in a continous manner |
| 02/05/2003 | EP1281703A1 Process for the preparation of 5-alkoxy-oxazoles as well as of pyridoxines |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1082121A4 Hiv integrase inhibitors |
| 02/05/2003 | EP0742201B1 Process for producing aromatic or heteroaromatic sulfur compounds |
| 02/05/2003 | CN1395569A Oxazolidinone thioamides with piperazine amide substituents |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1100768C Substituted diphenyl oxazolines |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/04/2003 | US6515176 Disclosed is a 6-acylamino-5-substituted-benzoxazol-2-one compound having the structural formula I: Also disclosed is a method for forming a cyan dye-forming coupler from the above compound. The method and intermediate with a simplified |
| 02/04/2003 | US6515136 To the novel intermediates prepared by these methods. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension. |
| 02/04/2003 | US6515135 Aminoaryl oxazolidinone N-oxides |
| 02/04/2003 | US6515014 Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 02/04/2003 | US6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 01/30/2003 | WO2003008411A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | WO2003008389A1 Oxazolidinone derivatives as potential antimicrobials |
| 01/30/2003 | WO2003007870A2 Oxazolidinone derivatives as antimicrobials |
| 01/30/2003 | WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/30/2003 | WO2002006267A3 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
| 01/30/2003 | US20030023098 Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
| 01/30/2003 | US20030023092 Reacting tetrahydrofuran compound with oxophilic electrophilic reagent to produce oxazoline compound |
| 01/30/2003 | CA2454059A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | CA2417804A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2003 | EP1279665A2 A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds |
| 01/29/2003 | EP1279656A2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
| 01/29/2003 | EP1278728A1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
| 01/29/2003 | EP1036074B1 S-oxide tetrahydrothiopyran phenyloxazolidinones |
| 01/29/2003 | CN1394207A Linezolid-crystal form II |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/28/2003 | US6512135 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate |
| 01/28/2003 | US6512121 Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 01/28/2003 | US6512112 Useful as prodrugs, easily convert to parent amine in vivo; antibiotic activity versus gram negative aerobic and anaerobic bacteria |
| 01/28/2003 | US6511813 Identifying compound which inhibits peptide bond reaction of a complex formed by interaction of EFP, N-formyl methionyl-tRNA, 30S subunit, 50S subunit, an mRNA containing AUG sequence, initiation factors 1, 2, 3, and peptide bond donor |
| 01/28/2003 | US6511670 (poly)thiaalkynoic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/23/2003 | WO2003006453A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003006442A1 Novel preparation process of 1,3-oxazole-2-thiol |
| 01/23/2003 | WO2003006441A1 Crystalline thiazine oxazolidinones |
| 01/23/2003 | WO2003006440A2 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006015A1 Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
| 01/23/2003 | WO2003006013A1 Diaminediols for the treatment of alzheimer's disease |